Maryam Kouchak

1.6k total citations
60 papers, 1.2k citations indexed

About

Maryam Kouchak is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Maryam Kouchak has authored 60 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmaceutical Science, 16 papers in Biomaterials and 14 papers in Molecular Biology. Recurrent topics in Maryam Kouchak's work include Advanced Drug Delivery Systems (19 papers), Drug Solubulity and Delivery Systems (11 papers) and RNA Interference and Gene Delivery (10 papers). Maryam Kouchak is often cited by papers focused on Advanced Drug Delivery Systems (19 papers), Drug Solubulity and Delivery Systems (11 papers) and RNA Interference and Gene Delivery (10 papers). Maryam Kouchak collaborates with scholars based in Iran and Lebanon. Maryam Kouchak's co-authors include Somayeh Handali, Zahra Ramezani, Eskandar Moghimipour, Farid Abedin Dorkoosh, Mohsen Rezaei, Kambiz Ahmadi Angali, Mohsen Amini, Nadereh Rahbar, Layasadat Khorsandi and Akram Ahangarpour and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Life Sciences.

In The Last Decade

Maryam Kouchak

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maryam Kouchak Iran 21 406 376 322 225 96 60 1.2k
Veera Venkata Satyanarayana Reddy Karri India 21 503 1.2× 359 1.0× 386 1.2× 273 1.2× 119 1.2× 80 1.6k
Asim Ur Rehman Pakistan 16 392 1.0× 289 0.8× 530 1.6× 297 1.3× 76 0.8× 43 1.4k
Md Habban Akhter India 21 358 0.9× 364 1.0× 361 1.1× 270 1.2× 52 0.5× 42 1.2k
Hatem A. Sarhan Egypt 20 477 1.2× 629 1.7× 318 1.0× 288 1.3× 77 0.8× 53 1.7k
Mohammad Imran India 22 255 0.6× 417 1.1× 350 1.1× 240 1.1× 67 0.7× 50 1.4k
Bader M. Aljaeid Saudi Arabia 17 453 1.1× 352 0.9× 528 1.6× 301 1.3× 86 0.9× 27 1.4k
D. Nagasamy Venkatesh India 10 494 1.2× 302 0.8× 367 1.1× 347 1.5× 95 1.0× 49 1.4k
Kalpana Nagpal India 19 493 1.2× 417 1.1× 668 2.1× 272 1.2× 129 1.3× 56 1.7k
Noha M. Zaki Egypt 16 345 0.8× 351 0.9× 576 1.8× 128 0.6× 85 0.9× 25 1.3k
Adel Al Fatease Saudi Arabia 21 333 0.8× 310 0.8× 256 0.8× 311 1.4× 118 1.2× 93 1.3k

Countries citing papers authored by Maryam Kouchak

Since Specialization
Citations

This map shows the geographic impact of Maryam Kouchak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maryam Kouchak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maryam Kouchak more than expected).

Fields of papers citing papers by Maryam Kouchak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maryam Kouchak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maryam Kouchak. The network helps show where Maryam Kouchak may publish in the future.

Co-authorship network of co-authors of Maryam Kouchak

This figure shows the co-authorship network connecting the top 25 collaborators of Maryam Kouchak. A scholar is included among the top collaborators of Maryam Kouchak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maryam Kouchak. Maryam Kouchak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rahbar, Nadereh, et al.. (2024). Chitosan/carbomer nanoparticles- laden in situ gel for improved ocular delivery of timolol: in vitro, in vivo, and ex vivo study. Drug Delivery and Translational Research. 15(4). 1210–1220. 5 indexed citations
4.
Kouchak, Maryam, et al.. (2022). What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review. Advanced Pharmaceutical Bulletin. 13(1). 7–23. 55 indexed citations
5.
Ahangarpour, Akram, Ali Akbar Oroojan, Layasadat Khorsandi, Maryam Kouchak, & Mohammad Badavi. (2021). Hypolipidemic and Hepatoprotective Effects of Myricitrin and Solid Lipid Nanoparticle-containing Myricitrin on the Male Mouse Model with Type 2 Diabetes Induced by Streptozotocin-Nicotinamide. SHILAP Revista de lepidopterología. 28(1). 32–42.
6.
Rahbar, Nadereh, et al.. (2021). Functionalized liposomes as drug nanocarriers for active targeted cancer therapy: a systematic review. Journal of Liposome Research. 32(2). 195–210. 35 indexed citations
7.
Kouchak, Maryam, et al.. (2021). Novel and efficient method for loading aptamer-conjugated liposomes with arsenic trioxide for targeting cancer cells. Journal of Liposome Research. 32(3). 276–283. 7 indexed citations
8.
Kouchak, Maryam, et al.. (2021). Oregano (Origanum vulgar subsp. viride) Essential Oil: Extraction, Preparation, Characterization, and Encapsulation by Chitosan-Carbomer Nanoparticles for Biomedical Application. Jundishapur Journal of Natural Pharmaceutical Products. 16(2). 3 indexed citations
9.
Neisi, Abdolkazem, et al.. (2018). The Effect of Preoperative Zintoma Capsule on Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy. Anesthesiology and Pain Medicine. In Press(In Press). e67132–e67132. 9 indexed citations
10.
Handali, Somayeh, Eskandar Moghimipour, Mohsen Rezaei, et al.. (2018). A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes. Biomedicine & Pharmacotherapy. 108. 1259–1273. 111 indexed citations
11.
Kouchak, Maryam, et al.. (2015). Preparation and In Vitro Evaluation of Chitosan Nanoparticles Containing Diclofenac Using the Ion-Gelation Method. Jundishapur Journal of Natural Pharmaceutical Products. 10(2). 25 indexed citations
12.
Majdinasab, Nastaran, et al.. (2013). Riboflavin Supplementation to Patients with Multiple Sclerosis does not Improve Disability Status nor is Riboflavin Supplementation Correlated to Homocysteine. International Journal for Vitamin and Nutrition Research. 83(5). 281–290. 23 indexed citations
13.
Kouchak, Maryam, et al.. (2012). Control of drug release from liquid preparations of iron. Research in Pharmaceutical Sciences. 7(5). 680. 1 indexed citations
14.
Kouchak, Maryam, et al.. (2012). Effect of different molecular weights of chitosan on preparation andcharacterization of insulin loaded nanoparticles by ion gelation method. International Journal of Drug Development and Research. 4(2). 27 indexed citations
15.
16.
Kouchak, Maryam, et al.. (2009). Comparison between the preventive effects of ranitidine and omeprazole on upper gastrointestinal bleeding among ICU patients.. 8(4). 37–42. 20 indexed citations
17.
Kouchak, Maryam, et al.. (2007). Preparation and In Vitro Evaluation of a Microballoon Delivery System for Theophylline. Iranian journal of pharmaceutical research. 6(1). 35–42. 9 indexed citations
18.
Farhadi, Mohammad, et al.. (2005). Comparison of Bleeding Extent in Propofol-Remifentanil Versus Isoflouran Remifentanil Anesthetic Procedures in Functional Endoscopy Sinus Surgery(FESS) in Rasoul-e-Akram Hospital. Razi Journal of Medical Sciences. 11(43). 737–742. 1 indexed citations
19.
Kouchak, Maryam & Fatemeh Atyabi. (2004). Ion-exchange, an Approach to Prepare an Oral Floating Drug Delivery System for Diclofenac. Iranian journal of pharmaceutical research. 3(2). 93–97. 14 indexed citations
20.
Pipelzadeh, Mohammad Hassan, et al.. (2002). CROMOGLYCATE: A HEALING AGENT IN ACUTE CHLORINE-INDUCED LUNG DAMAGE. DARU Journal of Pharmaceutical Sciences. 10(3). 120–124.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026